Farhan S Cyprian
Overview
Explore the profile of Farhan S Cyprian including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
539
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Abdallah A, Doudin A, Sulaiman T, Jamil O, Arif R, Sada F, et al.
Front Immunol
. 2024 May;
15:1353903.
PMID: 38799469
Introduction: The global healthcare burden of COVID-19 pandemic has been unprecedented with a high mortality. Metabolomics, a powerful technique, has been increasingly utilized to study the host response to infections...
2.
Anwardeen N, Cyprian F, Yassine H, Al-Thani A, Abdallah A, Emara M, et al.
Front Immunol
. 2023 May;
14:1146443.
PMID: 37122708
Background: The cross-protective nature of Bacillus Calmette-Guerin (BCG) vaccine against SARS-CoV-2 virus was previously suggested, however its effect in COVID-19 patients with type 2 diabetes (T2D) and the underlying metabolic...
3.
Nasarallah G, Fakhroo A, Khan T, Cyprian F, Al Ali F, Ata M, et al.
Mediterr J Hematol Infect Dis
. 2022 Nov;
14(1):e2022076.
PMID: 36425144
Background And Objectives: The heterogeneity of the coronavirus disease of 2019 (COVID-19) lies within its diverse symptoms and severity, ranging from mild to lethal. Acute respiratory distress syndrome (ARDS) is...
4.
Thomas S, Smatti M, Ouhtit A, Cyprian F, Almaslamani M, Thani A, et al.
Mol Immunol
. 2022 Nov;
152:172-182.
PMID: 36371813
Antibody-dependent enhancement (ADE) has been associated with severe disease outcomes in several viral infections, including respiratory infections. In vitro and in vivo studies showed that antibody-response to SARS-CoV and MERS-CoV...
5.
Diboun I, Cyprian F, Anwardeen N, Yassine H, Elrayess M, Rahmoon S, et al.
Front Cell Infect Microbiol
. 2022 Aug;
12:929689.
PMID: 35937683
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection currently remains one of the biggest global challenges that can lead to acute respiratory distress syndrome (CARDS) in severe cases. In line...
6.
Bansal D, Abdulmajeed J, Al-Shamali M, Albayat S, Himatt S, Cyprian F, et al.
Vaccines (Basel)
. 2022 Jul;
10(7).
PMID: 35891199
Waning immunity following administration of mRNA-based COVID-19 vaccines remains a concern for many health systems. We undertook a study to determine if recent reports of waning for severe disease could...
7.
Elrayess M, Cyprian F, Abdallah A, Emara M, Diboun I, Anwardeen N, et al.
Front Med (Lausanne)
. 2022 Jan;
8:788687.
PMID: 35083246
Increased COVID-19 disease severity is higher among patients with type 2 diabetes mellitus and hypertension. However, the metabolic pathways underlying this association are not fully characterized. This study aims to...
8.
Cyprian F, Suleman M, Abdelhafez I, Doudin A, Masud Danjuma I, Mir F, et al.
Front Immunol
. 2021 Dec;
12:707159.
PMID: 34966381
Coronavirus disease-2019 (COVID-19) was declared as a pandemic by WHO in March 2020. SARS-CoV-2 causes a wide range of illness from asymptomatic to life-threatening. There is an essential need to...
9.
Sasidharan Nair V, Saleh R, Toor S, Cyprian F, Elkord E
Cancer Immunol Immunother
. 2021 Jul;
70(8):2123.
PMID: 34232347
No abstract available.
10.
Kheraldine H, Gupta I, Alhussain H, Jabeen A, Cyprian F, Akhtar S, et al.
Comput Struct Biotechnol J
. 2021 Jun;
19:2881-2890.
PMID: 34093999
HER2-positive breast cancer is one of its most challenging subtypes, forming around 15-25% of the total cases. It is characterized by aggressive behavior and treatment resistance. On the other hand,...